IGT-303
Asset
- Stage
- Phase 1
- Modality
- Antibody
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Chronic kidney disease
Phase 1, Recruiting, NCT07231679, clinicaltrials.gov, 8 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.